These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15062056)

  • 1. [Expression of tyrosine kinase Syk in breast cancer and their clinical significance].
    Ding YB; Wu ZY; Wang S; Fan P; Zha XM; Zheng W; Liu XA
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):137-9. PubMed ID: 15062056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypermethylation of syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma].
    Ding YB; Wu ZY; Wang S; Zha XM; Zheng W; Liu XA; Fan P
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):290-3. PubMed ID: 15059510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
    Li J; Sidell N
    Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma.
    Wang S; Ding YB; Chen GY; Xia JG; Wu ZY
    World J Gastroenterol; 2004 Jun; 10(12):1815-8. PubMed ID: 15188513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of chemotactic factor receptor 5 gene with breast cancer.
    Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
    Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer.
    Toyama T; Iwase H; Yamashita H; Hara Y; Omoto Y; Sugiura H; Zhang Z; Fujii Y
    Cancer Lett; 2003 Jan; 189(1):97-102. PubMed ID: 12445683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
    Yuan Y; Mendez R; Sahin A; Dai JL
    Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive loss of Syk and abnormal proliferation in breast cancer cells.
    Moroni M; Soldatenkov V; Zhang L; Zhang Y; Stoica G; Gehan E; Rashidi B; Singh B; Ozdemirli M; Mueller SC
    Cancer Res; 2004 Oct; 64(20):7346-54. PubMed ID: 15492255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report.
    Inayat U; Kayani MA; Faryal R
    Pol J Pathol; 2012 Jun; 63(2):106-11. PubMed ID: 22864779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulatory role of Syk gene on vascular endothelial growth factor C expression in breast cancer].
    Chen XL; Li L; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):805-9. PubMed ID: 22336204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer.
    Ma L; Dong S; Zhang P; Xu N; Yan H; Liu H; Li Y; Zhou Q
    Clin Lab; 2010; 56(9-10):407-16. PubMed ID: 21086786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.
    Coopman PJ; Do MT; Barth M; Bowden ET; Hayes AJ; Basyuk E; Blancato JK; Vezza PR; McLeskey SW; Mangeat PH; Mueller SC
    Nature; 2000 Aug; 406(6797):742-7. PubMed ID: 10963601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of HRad17 mRNA in human breast cancer: correlation with lymph node metastasis.
    Kataoka A; Sadanaga N; Mimori K; Ueo H; Barnard GF; Sugimachi K; Auclair D; Chen LB; Mori M
    Clin Cancer Res; 2001 Sep; 7(9):2815-20. PubMed ID: 11555598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
    Yuan Y; Liu H; Sahin A; Dai JL
    Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of putative tumor suppressor gene spleen tyrosine kinase in esophageal squamous cell carcinoma.
    Dong SW; Zhang P; Zhong RR; Liu Q
    Clin Lab; 2013; 59(5-6):647-53. PubMed ID: 23865365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival.
    Dejmek J; Leandersson K; Manjer J; Bjartell A; Emdin SO; Vogel WF; Landberg G; Andersson T
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):520-8. PubMed ID: 15701836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syk: a new player in the field of breast cancer.
    Stewart ZA; Pietenpol JA
    Breast Cancer Res; 2001; 3(1):5-7. PubMed ID: 11250739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
    Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
    Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
    Goodman PA; Wood CM; Vassilev A; Mao C; Uckun FM
    Oncogene; 2001 Jul; 20(30):3969-78. PubMed ID: 11494125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.